New Alzheimer’s Drug Aducanumab Promising But “ARIA” Side Effects Require Careful Monitoring
A new drug recently approved for Alzheimer’s disease aims to treat the underlying cause of the condition by removing amyloid plaques in the brain. Though promising, the drug called aducanumab also comes with potential side effects that require careful monitori…
Read article